GlassScriptPhysician profile
Sandra K Rogers
NPI 1710423017
$7,877.12
in general payments reported to CMS, 2019-2025
39 companies · $2,012 in 2025
The $2,012 reported for 2025 was more than what 94% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $573 · 2022: $1,829 · 2023: $1,986 · 2024: $1,478 · 2025: $2,012.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,475.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,193.05 | 2021-2025 | |
| Novo Nordisk INC | $1,144.77 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $644.80 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Corcept Therapeutics | $467.11 | 2025 | Korlym |
| Astrazeneca Pharmaceuticals LP | $430.63 | 2021-2025 | Farxiga, Airsupra |
| Antares Pharma, INC. | $358.09 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| Pfizer INC. | $355.69 | 2023-2025 | |
| Exact Sciences Corporation | $279.84 | 2024-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $235.00 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $197.91 | 2022-2025 | Jardiance, Synjardy |
| Dexcom, INC. | $170.71 | 2024-2025 | Dexcom G6 Transmitter |
| Biohaven Pharmaceutical Holding Company LTD. | $163.14 | 2022 | |
| Noven Therapeutics, LLC | $156.99 | 2024-2025 | Xelstrym |
| Amgen INC. | $126.53 | 2023-2025 | Repatha, Krystexxa |
| Abbott Laboratories | $111.19 | 2021-2022 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Rogers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.